EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Clinical studies in CKD 1-5
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
435
Visits:
664
Title:
Improved Acid-Base status by a novel safe Citrate containing Acetate-free Hemodialysis Fluid
Authors:
Gunilla Grundstrm , Maria Alquist, Madeleine Holmquist, Anders Christensson, Peter Bjrk, Mohamed AbdGawad, Lars Ekholm, Mrten Segelmark
Centre:
Gambro Research
You must be registered to reply or comment.
IMPROVED ACID-BASE STATUS BY A NOVEL SAFE CITRATE CONTAINING ACETATE-FREE HEMODIALYSIS FLUID
Gunilla Grundstrm
Thread initiator
Subspeciality
Reg:
5/9/2012 6:46:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 5/9/2012 6:46:00 PM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2644
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
243
Visits:
2054
Title:
Improvement in Kidney Function after Cardiac Resynchronization Therapy
Authors:
Jesmar Buttigieg ,
Centre:
Mater Dei Hospital
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access